---
aliases: [Roivant, ROIV]
---
#actor #company #biotech #usa #public

**Roivant Sciences** — Biotech holding company with "vant" subsidiary model. Founded by Vivek Ramaswamy (2014). 20+ subsidiaries, 6 FDA approvals. NASDAQ: ROIV.

---

## Overview

| Metric | Value |
|--------|-------|
| Ticker | ROIV (NASDAQ) |
| Founded | 2014 |
| HQ | Basel, [[Switzerland]] (incorporated Bermuda) |
| Market cap | ~$6B+ |
| Subsidiaries | 20+ "vant" companies |
| FDA approvals | 6 |

---

## Business model

| Aspect | Description |
|--------|-------------|
| Strategy | Acquire underdeveloped drug patents, bring to market |
| Structure | Spin out focused subsidiaries ("vants") |
| Capital | Each vant separately funded, some go public |
| Exits | Sell successful vants to pharma |

---

## Key subsidiaries

| Subsidiary | Focus | Status |
|------------|-------|--------|
| Immunovant | Autoimmune | Public (majority-owned) |
| Dermavant | Medical dermatology | Commercial-stage |
| Kinevant | Rare autoimmune | Clinical-stage |
| Lokavant | Clinical trial monitoring | Active |
| Datavant | [[Healthcare]] data sharing | Merged with Ciox ($7B) |
| Priovant | Gene therapy | JV with Pfizer (25% Pfizer) |

---

## Major exits

| Year | Deal | Acquirer | Value |
|------|------|----------|-------|
| 2023 | Telavant | [[Roche]] | $7.1B (+$150M milestone) |
| 2020 | Portfolio (5 drugs + 10% stake) | Sumitomo Dainippon | $3B |

---

## Incubator function

Roivant incubates AI/biotech startups:

| Company | Focus | Status |
|---------|-------|--------|
| [[Proxima]] | [[AI drug discovery]] (protein interactions) | Spun out, $80M seed |

---

## Founder: Vivek Ramaswamy

| Metric | Value |
|--------|-------|
| Founded Roivant | 2014 (age 29) |
| Stepped down as CEO | January 2021 |
| Left board | February 2023 (presidential campaign) |
| Net worth | ~$2B (Forbes, Jan 2026) |
| Current role | Co-head of [[DOGE]] (Trump admin) |

**Current CEO:** Matt Gline (former CFO)

---

## Investors

Early backers included:
- QVT Financial
- RA Capital Management
- Visium Asset Management

---

*Created 2026-01-17*

---

## Related

- [[Proxima]] — incubated company ([[AI drug discovery]])
- [[Roche]] — acquirer (Telavant $7.1B)
- [[Pfizer]] — JV partner (Priovant)
- [[Biotech]] — sector
